Evaluating Cognitive Safety In Clinical Trials
Source: Signant Health

Understanding cognitive function is essential in drug development, especially when assessing activities that involve risk, such as driving or operating machinery. Signant’s SmartSignals® CDR System® offers a validated battery of cognitive tests to evaluate treatment effects on cognition with unrivaled accuracy and sensitivity. Delve into all the reasons choosing the CDR System® could benefit your early-phase cognitive safety studies.
access the Brochure!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
Signant Health
This website uses cookies to ensure you get the best experience on our website. Learn more